GlaxoSmithKline PLC Block listing Interim Review (7281N)
May 10 2018 - 12:20PM
UK Regulatory
TIDMGSK
RNS Number : 7281N
GlaxoSmithKline PLC
10 May 2018
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed
electronically and provided to an ris.
Date: 10 May 2018
Name of applicant: GlaxoSmithKline plc
------------------------------------------------------------ --------------------------------------------------------
Name of scheme: GlaxoSmithKline plc 2009 Deferred Annual Bonus Plan
------------------------------------------------------------ --------------------------------------------------------
Period of return: From: 1 November 2017 To: 30 April 2018
---------------------------------- ------------------------ ------------------------- ------ ---------------------
Balance of unallotted securities under scheme(s) from
previous return: 199,082
------------------------------------------------------------ --------------------------------------------------------
Plus: The amount by which the block scheme(s) has been
increased since the date of the last
return (if any increase has been applied for): 0
------------------------------------------------------------ --------------------------------------------------------
Less: Number of securities issued/allotted under scheme(s)
during period (see LR3.5.7G): 165,219
------------------------------------------------------------ --------------------------------------------------------
Equals: Balance under scheme(s) not yet issued/allotted at
end of period: 33,863
------------------------------------------------------------ --------------------------------------------------------
Name of contact: Victoria Whyte
------------------------------ ---------------
Telephone number of contact: 020 8047 5000
------------------------------ ---------------
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed
electronically and provided to an ris.
Date: 10 May 2018
Name of applicant: GlaxoSmithKline plc
------------------------------------------------------------ --------------------------------------------------------
Name of scheme: GlaxoSmithKline Share Option Plan - Ordinary Shares
------------------------------------------------------------ --------------------------------------------------------
Period of return: From: 1 November 2017 To: 30 April 2018
---------------------------------- ------------------------ ------------------------- ------ ---------------------
Balance of unallotted securities under scheme(s) from
previous return: 3,559,772
------------------------------------------------------------ --------------------------------------------------------
Plus: The amount by which the block scheme(s) has been
increased since the date of the last
return (if any increase has been applied for): 0
------------------------------------------------------------ --------------------------------------------------------
Less: Number of securities issued/allotted under scheme(s)
during period (see LR3.5.7G): 865,821
------------------------------------------------------------ --------------------------------------------------------
Equals: Balance under scheme(s) not yet issued/allotted at
end of period: 2,693,951
------------------------------------------------------------ --------------------------------------------------------
Name of contact: Victoria Whyte
------------------------------ ---------------
Telephone number of contact: 020 8047 5000
------------------------------ ---------------
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed
electronically and provided to an ris.
Date: 10 May 2018
Name of applicant: GlaxoSmithKline plc
------------------------------------------------------------------------ --------------------------------------------
Name of scheme: GlaxoSmithKline Share Option Plan - ADS
------------------------------------------------------------------------ --------------------------------------------
Period of return: From: 1 November 2017 To: 30 April 2018
---------------------------------------------- ------------------------ ------------------- ----- ----------------
Balance of unallotted securities under scheme(s) from previous return: 8,185,120
------------------------------------------------------------------------ --------------------------------------------
Plus: The amount by which the block scheme(s) has been increased since
the date of the last
return (if any increase has been applied for): 0
------------------------------------------------------------------------ --------------------------------------------
Less: Number of securities issued/allotted under scheme(s) during
period (see LR3.5.7G): 275,126
------------------------------------------------------------------------ --------------------------------------------
Equals: Balance under scheme(s) not yet issued/allotted at end of
period: 7,909,994
------------------------------------------------------------------------ --------------------------------------------
Name of contact: Victoria Whyte
------------------------------ ---------------
Telephone number of contact: 020 8047 5000
------------------------------ ---------------
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed
electronically and provided to an ris.
Date: 10 May 2018
Name of applicant: GlaxoSmithKline plc
----------------------------------------------------------------------- ---------------------------------------------
Name of scheme: GlaxoSmithKline plc Share Save Plan 2012
----------------------------------------------------------------------- ---------------------------------------------
Period of return: From: 1 November 2017 To: 30 April 2018
--------------------------------------------- ------------------------ -------------------- ----- ----------------
Balance of unallotted securities under scheme(s) from previous return: 1,542,070
----------------------------------------------------------------------- ---------------------------------------------
Plus: The amount by which the block scheme(s) has been increased since
the date of the last
return (if any increase has been applied for): 0
----------------------------------------------------------------------- ---------------------------------------------
Less: Number of securities issued/allotted under scheme(s) during
period (see LR3.5.7G): 714,764
----------------------------------------------------------------------- ---------------------------------------------
Equals: Balance under scheme(s) not yet issued/allotted at end of
period: 827,306
----------------------------------------------------------------------- ---------------------------------------------
Name of contact: Victoria Whyte
------------------------------ ---------------
Telephone number of contact: 020 8047 5000
------------------------------ ---------------
The following GlaxoSmithKline plc Employee Share Schemes have
expired and therefore will no longer be included in Block Listing
Six Monthly Returns:
1. Glaxo Wellcome UK Share Option Scheme
2. Glaxo Wellcome International Share Option Scheme
3. Glaxo Wellcome 1999 Share Option Plan
4. SmithKline Beecham 1989 Executive Share Option Plan - Approved - Ordinary Shares
5. SmithKline Beecham 1989 Executive Share Option Plan - Unapproved - ADS
6. SmithKline Beecham 1989 Executive Share Option Plan - Unapproved - Ordinary
This information is provided by RNS
The company news service from the London Stock Exchange
END
BLRMMGMKVGVGRZM
(END) Dow Jones Newswires
May 10, 2018 12:20 ET (16:20 GMT)
Gsk (LSE:GSK)
Historical Stock Chart
From Apr 2024 to May 2024
Gsk (LSE:GSK)
Historical Stock Chart
From May 2023 to May 2024
